Detection of breast malignancy: Diagnostic MR protocol for improved specificity

Radiology

Volumn 232, Issue 2, 2004, Pages 585-591

  Huang, Wei ^a,b   Fisher, Paul R ^a   Dulaimy, Khaldoon ^a   Tudorica, Luminita A ^a   O'Hea, Brian ^a   Button, Terry M ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Breast neoplasms, diagnosis; Breast neoplasms, MR; Magnetic resonance (MR), contrast enhancement; Magnetic resonance (MR), perfusion study; Magnetic resonance (MR), spectroscopy

Indexed keywords

CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; FEMALE; HUMAN; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTON NUCLEAR MAGNETIC RESONANCE; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; BIOPSY; BREAST; BREAST NEOPLASMS; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MAMMOGRAPHY; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE;

EID: 3242758914     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2322030547     Document Type: Article

References (37)

1. Harms SE. Technical report of the international working group on breast MRI. J Magn Reson Imaging 1999; 10:979-1015.
2. Knopp MV, Weiss E, Sinn HP, et al. Pathophysiologic basis of contrast enhancement in breast tumors. J Magn Reson Imaging 1999; 10:260-266.
3. Daniel BL, Yen YF, Glover GH, et al. Breast disease: dynamic spiral MR imaging. Radiology 1998; 209:499-509.
4. Kaiser W, Zeitler E. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Radiology 1989; 170:681-686.
5. Gilles R, Guinebretiere JM, Lucidarme O, et al. Nonpalpable breast tumors: diagnosis with contrast-enhanced subtraction dynamic MR imaging. Radiology 1994; 191:625-631.
6. Boetes C, Barentsz JO, Mus RD, et al. MR characterization of suspicious breast lesions with a gadolinium-enhanced turbo-FLASH subtraction technique. Radiology 1994; 193:777-781.
7. Chenevert TL, Helvie MA, Aisen AM, et al. Dynamic three-dimensional imaging with partial k-space sampling: initial application for gadolinium-enhanced rate characterization of breast lesions. Radiology 1995; 196:135-142.
8. Kelcz F, Santyr GE, Cron GO, Mongin SJ. Application of a quantitative model to differentiate benign from malignant breast lesions detected by dynamic, gadolinium-enhanced MRI. J Magn Reson Imaging 1996; 6:743-752.
9. Muller-Schimpfle M, Ohmenhauser K, Sand J, Stoll P, Claussen CD. Dynamic 3D-MR mammography: is there a benefit of sophisticated evaluation of enhancement curves for clinical routine? J Magn Reson Imaging 1997; 7:236-240.
10. Wiberg MK, Bone B, Bronge L, Aspelin P. Comparison of the contrast enhancement pattern in two different T1-weighted 3D sequences in MR imaging of the breast. Acta Radiol 1998; 39:680-685.
11. Nunes LW, Schnall MD, Orel SG, et al. Correlation of lesion appearance and histologic findings for the nodes of a breast MR imaging interpretation model. RadioGraphics 1999; 19:79-92.
12. Yen YF, Han KF, Daniel BL, et al. Dynamic breast MRI with spiral trajectories: 3D versus 2D. J Magn Reson Imaging 2000; 11:351-359.
13. Orel SG, Schnall MD, LiVolsi VA, Troupin RH. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. Radiology 1994; 190:485-493.
14. Brinck U, Fischer U, Korabiowska M, Jutrowski M, Schauer A, Grabbe E. The variability of fibroadenoma in contrast-enhanced dynamic MR mammography. AJR Am J Roentgenol 1997; 168:1331-1334.
15. Daldrup H, Shames DM, Wendland M, et al. Correlation of dynamic contrast-enhanced magnetic resonance imaging with histologic tumor grade: comparison of macromolecular and small molecular contrast media. AJR Am J Roentgenol 1998; 171:941-949.
16. Tofts P, Berkowitz B, Schnall M. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model. Magn Reson Med 1995; 33:564-568.
17. Yankeelov TE, Rooney W, Springer CS. CR bolus-tracking pharmacokinetic parameters: the effects of equilibrium transcytolemmal water exchange (abstr). In: Proceedings of the Ninth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2001; 2251.
18. Yankeelov TE, Rooney WD, Li X, Lee JH, Springer CS. Pharmacokinetic analysis is affected by fast-exchange-limit (FXL) departure during bolus CR passage (abstr). In: Proceedings of the 10th Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2002; 2116.
19. Kvistad KA, Rydland J, Vainio J, et al. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging. Radiology 2000; 216:545-553.
20. Kuhl CK, Bieling H, Gieseke J, et al. Breast neoplasm: T2* susceptibility-contrast, first-pass perfusion MR imaging. Radiology 1997; 202:87-95.
21. Yoshino A. Efficacy of dynamic susceptibility contrast MRI using echo-planar imaging in differential diagnosis of breast tumors. Nippon Acta Radiol 1998; 58:441-446.
22. Kvistad KA, Lundgren S, Fjosne HE, Smenes E, Smethurst HB, Haraldseth O. Differentiating benign and malignant breast lesions with T2-weighted first pass perfusion imaging. Acta Radiol 1999; 40:45-51.
23. Roebuck JR, Cecil KM, Schnall MD, Lenkinski RE. Human breast lesions: characterization with proton MR spectroscopy. Radiology 1998; 209:269-275.
24. Gribbestad IS, Singstad TE, Nilsen G, et al. In vivo 1H MRS of normal breast and breast tumors using a dedicated double breast coil. J Magn Reson Imaging 1998; 8:1191-1197.
25. Yeung DK, Yang WT, Tse GM. Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases. Radiology 2002; 225:190-197.
26. Yeung DK, Cheung HS, Tse GM. Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy - initial results. Radiology 2001; 220:40-46.
27. Negendank W. Studies of human tumors by MRS: a review. NMR Biomed 1992; 5:303-324.
28. Rosen BR, Belliveau JW, Vevea JM, Brady TJ. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990; 14:249-265.
29. Rostrup E, Larsson HBW, Toft PB, Garde K, Ring PB, Henriksen O. Susceptibility contrast imaging of CO2-induced changes in the blood volume of the human brain. Acta Radiol 1996; 37:813-822.
30. Koshimoto Y, Yamada H, Kimura H, et al. Quantitative analysis of cerebral microvascular hemodynamics with T2-weighted dynamic MR imaging. J Magn Reson Imaging 1999; 9:462-467.
31. Simonsen CZ, Ostergaard L, Smith DF, Vestergaard-Poulsen P, Gyldensted C. Comparison of gradient- and spin-echo imaging: CBF, CBV and MTT measurements by bolus tracking. J Magn Reson Imaging 2000; 12:411-416.
32. Speck O, Chang L, DeSilva NM, Ernst T. Perfusion MRI of the human brain with dynamic susceptibility contrast: gradientecho versus spin-echo techniques. J Magn Reson Imaging 2000; 12:381-387.
33. Padhani AR. Dynamic contrast-enhanced MRI studies in human tumors. Br J Radiol 1999; 72:427-431.
34. Padhani AR. Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J Magn Reson Imaging 2002; 16:407-422.
35. Landis CS, Li X, Telang FW, et al. Determination of the MRI contrast agent concentration time course in vivo following bolus injection: effect of equilibrium transcytolemmal water exchange. Magn Reson Med 2000; 44:563-574.
36. Kuhl CK, Bieling HB, Gieseke J, et al. Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclicalphase dependency. Radiology 1997; 203:137-144.
37. Muller-Schimpfle M, Ohmenhauser K, Stoll P, Dietz K, Claussen CD. Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology 1997; 203:145-149.